25I-NBMD

2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2,3-methylenedioxybenzyl)ethanamine

NBMD-2C-I, Cimbi-29

Psychoactive Class

Psychedelic Hallucinogen

Chemical Class

Phenethylamine (N-benzylated)

Dosage & Duration

Dosage

Threshold~800 ug

Light800-1500 ug

Moderate1500-2000 ug

Strong2000-3000 ug

Heavy3000+ ug

Duration

Onset20-40 minutes

After Effects1-8 hours

Total4-6 hours

Reagent Testing

Loading reagent data...

Pharmacology

Pharmacodynamics

History & Culture

25I-NBMD was discovered in 2006 by a research team at Purdue University led by David Nichols. The compound is a derivative of the phenethylamine hallucinogen 2C-I, developed as part of ongoing investigations into serotonin receptor pharmacology.…

Legality

By Country

SwedenSchedule I (Narcotic Drugs Punishments Act)

Classified under Swedish schedule I, which covers substances without recognized medical use. Added on January 16, 2015, through Medical Products Agency regulation LVFS 2014:11.

United KingdomClass A

Controlled under the Misuse of Drugs Act 1971 through the N-benzylphenethylamine catch-all clause. Class A substances carry the most severe penalties, with possession punishable by up to seven years imprisonment and supply offenses carrying potential life sentences.

Sources

PsychonautWiki: 25I-NBOMe (similar compound)https://psychonautwiki.org/wiki/25I-NBOMe
TripSit: 25I-NBMD Factsheethttps://drugs.tripsit.me/25i-nbmd
Wikipediahttps://en.wikipedia.org/wiki/25I-NBMD